Suncoast Equity Management purchased a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 19,220 shares of the financial services provider's stock, valued at approximately $3,566,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its position in shares of Marsh & McLennan Companies by 51.2% in the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider's stock worth $1,856,000 after purchasing an additional 2,960 shares during the last quarter. Bison Wealth LLC raised its position in shares of Marsh & McLennan Companies by 39.6% in the 4th quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider's stock worth $651,000 after purchasing an additional 869 shares during the last quarter. Glenview Trust co raised its position in shares of Marsh & McLennan Companies by 10.8% in the 2nd quarter. Glenview Trust co now owns 3,897 shares of the financial services provider's stock worth $852,000 after purchasing an additional 379 shares during the last quarter. Osterweis Capital Management Inc. raised its position in shares of Marsh & McLennan Companies by 18,440.0% in the 2nd quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider's stock worth $203,000 after purchasing an additional 922 shares during the last quarter. Finally, Diversify Advisory Services LLC purchased a new position in shares of Marsh & McLennan Companies in the 2nd quarter worth about $1,307,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities analysts have recently issued reports on MRSH shares. JPMorgan Chase & Co. lowered their price target on Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating for the company in a research report on Thursday, April 9th. Piper Sandler lowered their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a "neutral" rating for the company in a research report on Tuesday, May 26th. Bank of America dropped their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an "underperform" rating on the stock in a research report on Tuesday, April 14th. Barclays dropped their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 8th. Finally, Cantor Fitzgerald increased their price objective on Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an "overweight" rating in a research report on Monday, February 2nd. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Marsh & McLennan Companies has a consensus rating of "Hold" and a consensus price target of $203.56.
View Our Latest Analysis on MRSH
Insider Transactions at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,655 shares of Marsh & McLennan Companies stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the sale, the chief executive officer owned 116,811 shares of the company's stock, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.38% of the company's stock.
Marsh & McLennan Companies Stock Down 0.1%
Marsh & McLennan Companies stock opened at $159.73 on Monday. The company's 50-day moving average price is $164.87. The company has a market cap of $77.17 billion, a P/E ratio of 19.97, a P/E/G ratio of 2.33 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 52-week low of $157.74 and a 52-week high of $235.78. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last released its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The business had revenue of $7.30 billion during the quarter. The business's quarterly revenue was up 7.6% on a year-over-year basis. Research analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.
Marsh & McLennan Companies Company Profile
(
Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Articles
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.